[{"address1": "4 Kingsbury Avenue", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "617 607 0800", "fax": "617 607 0530", "website": "https://www.enanta.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay R. Luly Ph.D.", "age": 68, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 1231428, "exercisedValue": 0, "unexercisedValue": 67815}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.89, "open": 8.965, "dayLow": 8.72, "dayHigh": 9.06, "regularMarketPreviousClose": 8.89, "regularMarketOpen": 8.965, "regularMarketDayLow": 8.72, "regularMarketDayHigh": 9.06, "payoutRatio": 0.0, "beta": 0.845, "forwardPE": -1.8360996, "volume": 102681, "regularMarketVolume": 102681, "averageVolume": 175216, "averageVolume10days": 137680, "averageDailyVolume10Day": 137680, "bid": 8.79, "ask": 8.89, "bidSize": 1, "askSize": 2, "marketCap": 189194416, "fiftyTwoWeekLow": 4.09, "fiftyTwoWeekHigh": 13.37, "priceToSalesTrailing12Months": 2.9193966, "fiftyDayAverage": 7.7478, "twoHundredDayAverage": 6.72455, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 192181616, "profitMargins": -1.41981, "floatShares": 14331332, "sharesOutstanding": 21377900, "sharesShort": 2884903, "sharesShortPriorMonth": 2463124, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.1349, "heldPercentInsiders": 0.06554, "heldPercentInstitutions": 0.86583, "shortRatio": 16.3, "shortPercentOfFloat": 0.1434, "impliedSharesOutstanding": 21377900, "bookValue": 3.708, "priceToBook": 2.3867316, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -92012000, "trailingEps": -4.32, "forwardEps": -4.82, "enterpriseToRevenue": 2.965, "enterpriseToEbitda": -2.066, "52WeekChange": -0.23903698, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 8.85, "targetHighPrice": 25.0, "targetLowPrice": 7.0, "targetMeanPrice": 18.57143, "targetMedianPrice": 20.0, "recommendationMean": 1.85714, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 204111008, "totalCashPerShare": 9.548, "ebitda": -93036000, "totalDebt": 207098000, "quickRatio": 4.769, "currentRatio": 4.999, "totalRevenue": 64806000, "debtToEquity": 261.227, "revenuePerShare": 3.044, "returnOnAssets": -0.17292, "returnOnEquity": -0.80644, "grossProfits": 64806000, "freeCashflow": -30994500, "operatingCashflow": -23183000, "revenueGrowth": 0.019, "grossMargins": 1.0, "ebitdaMargins": -1.43561, "operatingMargins": -1.03162, "financialCurrency": "USD", "symbol": "ENTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Enanta Pharmaceuticals, Inc.", "longName": "Enanta Pharmaceuticals, Inc.", "regularMarketChangePercent": -0.449943, "regularMarketPrice": 8.85, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1757111747, "regularMarketTime": 1757102402, "fiftyDayAverageChange": 1.1022005, "fiftyDayAverageChangePercent": 0.1422598, "twoHundredDayAverageChange": 2.1254506, "twoHundredDayAverageChangePercent": 0.3160733, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "exchange": "NMS", "messageBoardId": "finmb_345286", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1363872600000, "postMarketChangePercent": 1.581914, "postMarketPrice": 8.99, "postMarketChange": 0.13999939, "regularMarketChange": -0.04, "regularMarketDayRange": "8.72 - 9.06", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 175216, "fiftyTwoWeekLowChange": 4.76, "fiftyTwoWeekLowChangePercent": 1.1638142, "fiftyTwoWeekRange": "4.09 - 13.37", "fiftyTwoWeekHighChange": -4.5199995, "fiftyTwoWeekHighChangePercent": -0.33807027, "fiftyTwoWeekChangePercent": -23.903698, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1754942400, "earningsCallTimestampStart": 1715027400, "earningsCallTimestampEnd": 1715027400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.32, "epsForward": -4.82, "epsCurrentYear": -3.71667, "priceEpsCurrentYear": -2.3811638, "esgPopulated": false, "displayName": "Enanta Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]